Effects of Docosahexaenoic Acid Supplementation on Blood Pressure, Heart Rate, and Serum Lipids in Scottish Men with Hypertension and Hypercholesterolemia
Table 4
Body weight, heart rate, blood pressure, and lipid profiles in the two groups at baseline and at 5 weeks.
Parameter
Placebo ()
DHA ()
Baseline
5 Weeks
Baseline
5 Weeks
Weight (kg)
83.7 ± 11.8
83.3 ± 11.4
82.7 ± 12.3
83.1 ± 12.3
Heart rate (bpm)
70.7 ± 14.4
67.0 ± 10.3
70.4 ± 9.8
64.8 ± 9.2*
Systolic BP (mmHg)
132.7 ± 15.9
128.7 ± 16.3
141.4 ± 13.5
133.0 ± 12.9***
Diastolic BP (mmHg)
80.3 ± 10.5
77.9 ± 9.7
86.7 ± 10.4
81.9 ± 9.3**
TC (mg/dL)
228.9 ± 36.6
226.4 ± 36.6
253.6 ± 45.9
247.7 ± 40.5
HDL-C (mg/dL)
54.8 ± 12.7
59.3 ± 11.1**
55.5 ± 17.3
64.1 ± 20.4**
Non- HDL-C (mg/dL)
174.1 ± 39.8
167.2 ± 36.6
198.1 ± 48.7
183.6 ± 42.0
TC/HDL-C
4.4 ± 1.2
3.9 ± 0.8**
4.8 ± 1.3
4.1 ± 0.9**
Non-HDL-C/HDL-C
3.4 ± 1.2
2.9 ± 0.8**
3.8 ± 1.3
3.1 ± 0.9**
Placebo: Olive oil-containing bread rolls, DHA: DHA-containing bread rolls. Values are presented as mean ± SD. *, **, and *** compared with the baselines.
